Mankind Pharma Ltd

Mankind Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Mankind Pharma Ltd

₹ 2,436 -0.07%
23 May 3:10 p.m.
mankindpharma.com BSE: 543904 NSE: MANKIND
About

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.[1]

Key Points

Leadership[1]
- 1 Rank in Prescriptions over the last 5 yrs.
- Youngest in the Top 5 of the IPM
- 4 By value in the IPM
- 4 Consumer Healthcare brands Market ranked
1 in their categories

Website BSE NSE
  • Market Cap ₹ 1,00,512 Cr.
  • Current Price ₹ 2,436
  • High / Low ₹ 3,055 / 1,901
  • Stock P/E 50.6
  • Book Value ₹ 347
  • Dividend Yield 0.00 %
  • ROCE 17.9 %
  • ROE 16.8 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 7.05 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 33.3 to 46.0 days.
  • Working capital days have increased from 66.0 days to 112 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE 500 BSE Healthcare BSE 200 Nifty 500 Nifty Pharma

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1,726 2,180 2,426 2,091 2,053 2,579 2,708 2,607 2,422 2,893 3,077 3,199 3,079
1,441 1,724 1,835 1,654 1,636 1,924 2,025 2,000 1,836 2,212 2,226 2,383 2,396
Operating Profit 285 456 591 437 417 655 683 606 586 682 850 816 683
OPM % 16% 21% 24% 21% 20% 25% 25% 23% 24% 24% 28% 26% 22%
39 20 31 40 50 63 63 75 94 105 112 87 249
Interest 13 16 10 13 5 6 9 9 9 11 7 221 191
Depreciation 47 78 79 85 85 87 96 110 100 108 106 187 231
Profit before tax 263 382 533 379 377 624 641 562 572 668 849 495 511
Tax % 27% 22% 21% 22% 22% 21% 20% 18% 17% 19% 22% 22% 17%
193 298 423 296 294 494 511 460 477 543 659 385 425
EPS in Rs 4.75 7.30 10.48 7.09 7.13 12.15 12.51 11.33 11.76 13.39 16.31 9.22 10.20
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3,334 5,865 6,214 7,782 8,749 10,335 12,207
2,748 4,427 4,565 5,791 6,848 7,796 9,190
Operating Profit 586 1,438 1,649 1,991 1,902 2,538 3,018
OPM % 18% 25% 27% 26% 22% 25% 25%
76 122 183 210 141 294 554
Interest 2 23 21 60 46 35 429
Depreciation 39 99 119 167 326 398 621
Profit before tax 621 1,438 1,692 1,975 1,671 2,399 2,521
Tax % 29% 27% 24% 26% 22% 19% 20%
445 1,056 1,293 1,453 1,310 1,942 2,011
EPS in Rs 219.33 25.72 31.59 35.78 32.00 47.75 48.26
Dividend Payout % 0% 0% 24% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 14%
5 Years: 16%
3 Years: 16%
TTM: 18%
Compounded Profit Growth
10 Years: 16%
5 Years: 15%
3 Years: 13%
TTM: 10%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 16%
Return on Equity
10 Years: %
5 Years: 21%
3 Years: 19%
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 20 40 40 40 40 40 41
Reserves 2,035 3,445 4,682 6,115 7,395 9,323 14,291
0 131 241 873 170 207 8,511
968 1,449 1,397 2,080 2,080 2,313 4,916
Total Liabilities 3,022 5,065 6,360 9,108 9,686 11,883 27,760
316 1,600 1,664 3,588 4,251 4,545 19,524
CWIP 47 317 372 701 550 282 306
Investments 959 829 1,512 1,109 1,346 2,568 2,042
1,700 2,319 2,811 3,709 3,538 4,488 5,887
Total Assets 3,022 5,065 6,360 9,108 9,686 11,883 27,760

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,070 1,137 920 1,813 2,152 2,413
-436 -1,222 -1,369 -1,052 -2,081 -12,683
-531 -8 605 -740 5 10,233
Net Cash Flow 103 -92 156 22 77 -37

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 22 33 19 18 24 30 46
Inventory Days 166 175 243 265 188 179 219
Days Payable 71 145 137 162 126 127 119
Cash Conversion Cycle 117 63 125 121 86 82 146
Working Capital Days 56 35 43 62 45 41 112
ROCE % 37% 32% 22% 26% 18%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
76.50% 76.50% 76.50% 74.88% 74.87% 74.87% 72.71% 72.70%
4.18% 4.18% 6.74% 9.87% 11.58% 12.37% 13.34% 12.92%
4.65% 4.56% 9.78% 11.14% 9.94% 9.91% 11.05% 11.47%
14.67% 14.76% 6.97% 4.10% 3.61% 2.86% 2.89% 2.89%
No. of Shareholders 1,31,9181,34,7311,27,4491,35,1161,53,4501,63,8541,71,2811,80,597

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls